In last trading session, T2 Biosystems Inc (NASDAQ:TTOO) saw 0.53 million shares changing hands with its beta currently measuring 0.43. Company’s recent per share price level of $0.35 trading at $0.02 or 4.76% at ring of the bell on the day assigns it a market valuation of $7.36M. That closing price of TTOO’s stock is at a discount of -2294.29% from its 52-week high price of $8.38 and is indicating a premium of 11.43% from its 52-week low price of $0.31. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.87 million shares which gives us an average trading volume of 780.35K if we extend that period to 3-months.
T2 Biosystems Inc (NASDAQ:TTOO) trade information
Upright in the green during last session for gaining 4.76%, in the last five days TTOO remained trading in the red while hitting it’s week-highest on Monday, 12/16/24 when the stock touched $0.35 price level, adding 12.5% to its value on the day. T2 Biosystems Inc’s shares saw a change of -94.42% in year-to-date performance and have moved -4.11% in past 5-day. T2 Biosystems Inc (NASDAQ:TTOO) showed a performance of -24.21% in past 30-days. Number of shares sold short was 0.83 million shares which calculate 1.26 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of 5 to the stock, which implies a rise of 93.0% to its current value. Analysts have been projecting 5 as a low price target for the stock while placing it at a high target of 5. It follows that stock’s current price would drop -1328.57% in reaching the projected high whereas dropping to the targeted low would mean a loss of -1328.57% for stock’s current value.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 68.62% during past 5 years.
T2 Biosystems Inc (NASDAQ:TTOO)’s Major holders
Insiders are in possession of 10.17% of company’s total shares while institution are holding 73.51 percent of that, with stock having share float percentage of 81.83%. Investors also watch the number of corporate investors in a company very closely, which is 73.51% institutions for T2 Biosystems Inc that are currently holding shares of the company.